Remove scisparc-signs-agreement-for-the-supply-of-cbd-rich-cannabis-oil-for-its-clinical-trial-on-children-with-autism-spectrum-disorder
article thumbnail

SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder

Medical Marijuana Program Connection

The cannabis oil will be used as a part of the Company‘s proprietary SCI-210 treatment combination of CBD and CannAmide™ TEL. Read More